Kinetin
CAS 525-79-1
Kinetin (CAS 525-79-1) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 27761.430625 nM | 32 | - |
| - | Potency | 11991.317647058822 nM | 16 | - |
| - | IC50 | 16370.524 nM | 4 | - |
| - | Ki | 3200 nM | 1 | - |
| Endochitinase Enzyme |
Ki | 5.49 | - | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| kinetin | 16054 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Kinetin used for in pharmaceutical contexts?
Kinetin (CAS 525-79-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Kinetin?
No adverse-event association or SIDER side-effect rows are rendered for Kinetin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Kinetin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Kinetin with EU status "permitted".
What clinical phase is Kinetin in?
No phase 1-4 clinical development badge is rendered for Kinetin because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Kinetin?
Kinetin has 5 bioactivity rows in this page query. Rendered target entries include Endochitinase.